News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-05 7:4:4 am Rare Stock Picks In February 2024 - From 32 Discerning Analysts SeekingAlpha
2024-02-26 4:0:0 am Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China Business Wire
2024-02-23 5:15:0 pm Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira® Business Wire
2024-02-20 5:30:0 am Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting Business Wire
2024-02-20 1:43:22 am UPDATE 2-Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO Reuters
2024-02-20 1:0:27 am Teva Pharm to stay as unified generics, branded drugmaker -CEO says Reuters
2024-02-16 6:4:34 am Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript Insider Monkey
2024-02-16 5:57:31 am Q4 2023 Corcept Therapeutics Inc Earnings Call Thomson Reuters StreetEvents
2024-02-12 9:8:33 pm Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight GuruFocus.com
   

Please consider a small donation if you think this website provides you with relevant information